LVIS

LVIS Corporation is a neurotechnology company developing AI-powered clinical diagnostics for neurological disease. Founded in 2011 by Jin Hyung Lee, PhD (a Stanford professor), LVIS is headquartered in Palo Alto, California, with offices in Gangnam, Seoul and Daegu, South Korea. Its flagship product, NeuroMatch, is a cloud-based EEG analysis platform that decodes brain networks and provides visualizations to assist clinicians in diagnosing neurological conditions including epilepsy. Key features include automated EEG report generation, artifact reduction, longitudinal patient reports, and browser-based access with role-based controls. LVIS has raised $18 million across two rounds (Series A in 2018, Series B in 2022), with investors including SK Networks and SK. The company has been part of Stanford StartX, the Stanford Byers Center for Biodesign Faculty Fellowship Program, and the NVIDIA Inception program, and is a recipient of the Stanford Spectrum grant and the Epilepsy Foundation research grant. LVIS received a Silver Award at the 2026 Edison Awards for AI-Powered Neurological Diagnostics.